Precision BioSciences, Inc.
DTIL
$4.62
-$0.13-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.54% | 111.69% | 111.73% | 118.98% | 74.50% |
| Total Depreciation and Amortization | -47.93% | -44.55% | -40.09% | -30.31% | -17.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.91% | -255.12% | -148.75% | -144.02% | -113.48% |
| Change in Net Operating Assets | 25.30% | -30.16% | 3.79% | -2,904.74% | -369.88% |
| Cash from Operations | 18.31% | 30.52% | 50.60% | -44.44% | -48.17% |
| Capital Expenditure | 85.02% | 87.23% | 95.14% | 85.72% | 49.64% |
| Sale of Property, Plant, and Equipment | -100.00% | -43.93% | 38.57% | 38.57% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -103.49% | -100.33% | 2,751.33% | 3,271.60% | 4,039.50% |
| Cash from Investing | -107.71% | -103.69% | -101.47% | 315.83% | 302.48% |
| Total Debt Issued | -- | -- | 449,860.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -52.92% | 831.32% | 1,723.52% | 1,579.18% | -39.24% |
| Repurchase of Common Stock | -- | -- | -- | -70.00% | -70.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.97% | 836.51% | 1,750.64% | 1,706.51% | -52.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -86.47% | 88.74% | 98.99% | 69.31% | -148.59% |